ADPT
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Adaptive Biotechnologies announced an NCCN Guidelines update strengthening MRD testing recommendations and specifically referencing clonoSEQSep 17, 2026
- Adaptive Biotechnologies showcases clonoSEQ MRD assessment at ASCO and EHA 2025, optimizing patient care and drug development in lymphoid cancersMay 30, 2025